Wang, Hua
Peng, Zhiyou
Li, Yiwen
Sahn, James J.
Hodges, Timothy R.
Chou, Tsung-Han
Liu, Qiong
Zhou, Xuezhi
Jiao, Shuliang
Porciatti, Vittorio
Liebl, Daniel J.
Martin, Stephen F.
Wen, Rong
Funding for this research was provided by:
Hope For Vision (Grant, Grant)
Office of Extramural Research, National Institutes of Health (R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;, R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;, R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;)
Miami Project to Cure Paralysis (Support)
Welch Foundation (F-0652)
Dell Medical School, University of Texas at Austin (Texas Health Catalyst program)
Article History
Received: 10 March 2022
Accepted: 16 November 2022
First Online: 1 December 2022
Competing interests
: The authors declare the following competing financial interest(s): S.F.M., J.J.S., and T.R.H. are co-inventors of pending patent applications related to the work described in this article. S.F.M. and J.J.S. are cofounders of NuvoNuro, Inc. H.W., Z.P., Y.L., T.H.C., Q.L., X.Z., S.J., V.P., D.J.L., and R.W. do not have any competing interests to declare.